Abstract
Worldwide, the treatment of tuberculosis is based on evidence-based guidelines developed by the World Health Organization (WHO) for national tuberculosis programs. However, the importance of health related quality of life, the adequate management of side effects associated with antituberculosis drugs and the elaboration of tuberculosis treatment outcome categories are a few issues that need to be addressed in forthcoming WHO guidelines for the treatment of tuberculosis.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antitubercular Agents / adverse effects*
-
Antitubercular Agents / therapeutic use
-
Exanthema / chemically induced
-
Exanthema / drug therapy*
-
Guidelines as Topic
-
Histamine Antagonists / therapeutic use
-
Humans
-
Pruritus / chemically induced
-
Pruritus / drug therapy*
-
Quality of Life / psychology
-
Treatment Outcome
-
Tuberculosis / drug therapy*
-
Tuberculosis / psychology*
-
World Health Organization*
Substances
-
Antitubercular Agents
-
Histamine Antagonists